Ursodeoxycholic Acid

Ursodeoxycholic Acid is a premium-grade, white crystalline powder bile acid compound carrying CAS number 128-13-2. Processed under strict pharmaceutical compliance, this high-purity hydrophilic acid derivative exhibits exceptional cytoprotective and anti-cholestatic profiles, making it an ideal core choice for manufacturing clinical-strength hepatic therapy tablets, specialized digestive supplements, and advanced hepatobiliary research formulations globally.

SKU: 128-13-2 Category: Tag:
Description
Ursodeoxycholic Acid represents an elite-grade therapeutic bile acid refined under strict molecular quality guidelines to fulfill advanced pharmaceutical compounding and factory production standards. Zyntex supplies high-purity Ursodeoxycholic Acid (CAS 128-13-2) tailored specifically for global pharmaceutical manufacturing plants, clinical research laboratories, and international hepatology drug development loops. Functioning as a highly specific membrane stabilizer and biliary regulator, it delivers precise substance profiles that ensure uniform dry batch integration and highly predictable dissolution kinetics in solid-dose manufacturing matrices. Furthermore, its strictly minimized chemical volatile impurities and optimized crystal particle size geometry make it an ideal selection for sensitive oral capsule compounding. Accordingly, formulation scientists specify this active substance to stabilize modern hepatic drug carriers and maintain exact dosage integrity across continuous processing cycles.

Cytoprotective Mechanics and Biliary Stability Profiles

Excellent crystalline dissolution behavior and outstanding hepatocyte membrane permeability profiles provide a distinct operational edge when engineering modern fast-acting liver treatments. This active pharmaceutical solid operates by reducing the detergent effects of toxic bile acids, supplying the exact biological mechanisms required to protect liver cells without altering raw binder uniformity. It assists compounding engineers in maintaining strict dosage uniformity across high-speed compression runs, mitigating trace separation risks within automated volumetric feeding systems. For instance, specialized pharmaceutical facilities incorporate this hydrophilic acid derivative compound as a core active component in targeted hepatobiliary tablet lines. As a consequence, it maximizes the technical throughput of automated filling machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream polymorph shifts from your factory schedule.

In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale trials and advanced hepatology formulation research centers. The compound maintains its refined crystalline integrity under strict storage parameters, preventing heat-induced chemical breakdown or structural degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable hepatic raw material that meets international monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) calibrations and bioanalytical validation testing assays. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial tablet batches and the analytical rigor of specialized industrial laboratories.

Primary Medical Sectors for Ursodeoxycholic Acid

This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:

💊 Tablet Compression

Primary active pharmaceutical source used for compressing uniform, clinical-grade oral liver-support tablets. Hence, it directly supports optimal dosage control lines.

🧪 Capsule Compounding

Utilized as a high-purity active base to pack hard-shell oral capsules and multi-component therapeutic formulas. Clearly, it is key for uniform dissolving patterns.

🔬 Chromatographic Assays

Acts as an essential reference active standard for membrane stabilization metrics, assay calibration, and routine laboratory diagnostics. Resultantly, it guarantees excellent matrix clarity.

🏢 Hepatology Research

Used as a professional active component for engineering advanced liver-tissue models and specialized liposomal drug carriers. Specifically, it confirms optimal reaction pathways.

Technical Specifications

ParameterStandard Value
Product NameUrsodeoxycholic Acid
Assay / Purity (HPLC)98.5% to 101.0% (Dry Basis)
AppearanceWhite or almost white crystalline powder
Specific Rotation+57.0° to +62.0°
SolubilityPractically insoluble in water; freely soluble in ethanol and glacial acetic acid
CAS Number128-13-2

📝 Safety & Handling: Ursodeoxycholic Acid is a potent hepatoprotective active ingredient. Direct inhalation of crystalline bulk powder dust or accidental eye exposure can trigger immediate localized sensitization, dermatological stress, and respiratory tract mucosal irritation. Therefore, store strictly inside original airtight industrial drums within a well-ventilated, dry warehouse zone protected from light, moisture, and elevated temperatures. Prevent airborne dust clouds during dispensing loops. Proper personal protective equipment (PPE)—including chemical-resistant nitrile gloves, safety glasses with side shields, and a certified dust respirator mask—must be worn during all manufacturing handling phases. Review the Safety Data Sheet (SDS).